Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait

키워드

참고문헌 (15)

1. Dufour JF, "Current therapies and new developments in NASH", Gut, 71, pp.2123~2134 (2022)
2. Friedman SL, "Mechanisms of NAFLD development and therapeutic strategies", Nat Med, 24, pp.908~922 (2018)
3. Sookoian S, "Repurposing drugs to target nonalcoholic steatohepatitis", World J Gastroenterol, 25, pp.1783~1796 (2019)
4. 이승민, "Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways", Clinical and Molecular Hepatology, 28(4), pp.827~840 (2022), 대한간학회
5. Hwangbo H, "Auranofin attenuates non-alcoholic fatty liver disease by suppressing lipid accumulation and NLRP3 inflammasome-mediated hepatic inflammation in vivo and in vitro", Antioxidants(Basel), 9, pp.1040~ (2020)
6. Shinha Han, "Auranofin Inhibits Overproduction of Pro-Inflammatory Cytokines, Cyclooxygenase Expression and PGE2 Production in Macrophages", Archives of Pharmacal Research, 31(1), pp.67~74 (2008), 대한약학회
7. Roder C, "Auranofin : repurposing an old drug for a golden new age", Drugs R D, 15, pp.13~20 (2015)
8. Rothan HA, "The FDA-approved gold drug auranofin inhibits novel coronavirus(SARS-COV-2)replication and attenuates inflammation in human cells", Virology, 547, pp.7~11 (2020)
9. Fan C, "Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo", Cell Death Dis, 5, pp.e1191~ (2014)
10. Sookoian S, "PNPLA3, the triacylglycerol synthesis", hydrolysis, World J Gastroenterol, pp.2012, 18[DOI]
11. Sookoian S, "PNPLA3, the history of an orphan gene of the potato tuber protein family that found an organ : the liver", Hepatology, 59, pp.2068~2071 (2014)
12. Pirola CJ, "Epigenetics factors in nonalcoholic fatty liver disease", Expert Rev Gastroenterol Hepatol, 16, pp.521~536 (2022)
13. Sookoian S, "Genetic variants in STAT3 are associated with nonalcoholic fatty liver disease", Cytokine, 44, pp.201~206 (2008)
14. Sookoian S, "Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease", Atherosclerosis, 218, pp.378~385 (2011)
15. Sutton BM, "Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes", J Med Chem, 15, pp.1095~1098 (1972)

관련 논문AI추천